Janssen-Cilag Kft.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of Guselkumab Given After Ustekinumab in Participants With Moderate to Severe Psoriasis in Routine Clinical Practice (NCT07746583) | Janssen-Cilag Kft. | 2026-08-07 |
Track Janssen-Cilag Kft. automatically
Every clearance here is in the API, with alerts when new ones post.